Nebojša Cekić

Nebojša Cekić

Auto-generated profile, based on publicly available information

Nebojša Cekić

Faculty of Technology, University of Niš, Leskovac, Serbia; DCP Hemigal, Leskovac, Serbia

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2011 in International Journal of Cosmetic Science
Verified
Journal Article
Closed access
PDF file
Milica LukicMilica Lukic
Milica Lukic
Ivana PantelicIvana Pantelic
Ivana Pantelic
VKV. Krstonosic
V. Krstonosic
NCN. Cekic
N. Cekic
Snezana SavicSnezana Savic
Snezana Savic

1 September 2015 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
SĐSanela M. Đorđević
Sanela M. Đorđević
NCNebojša D. Cekić
Nebojša D. Cekić
MSMiroslav Savić
Miroslav Savić
TITanja M. Isailović
Tanja M. Isailović
DRDanijela V. Ranđelović
Danijela V. Ranđelović
Snezana SavicSnezana Savic
Snezana Savic
This paper describes design and evaluation of parenteral lecithin-based nanoemulsions intended for brain delivery of risperidone, a poorly water-soluble psychopharmacological drug. The nanoemulsions were prepared through cold/hot high pressure homogenization and characterized regarding droplet size, polydispersity, surface charge, morphology, drug-vehicle interactions, and physical stability. To estimate the simultaneous influence of nanoemulsion formulation and preparation parameters--co-emulsifier type, aqueous phase type, homogenization temperature--on the critical quality attributes of developed nanoemulsions, a general factorial experimental design was applied. From the established design space and stability data, promising risperidone-loaded nanoemulsions (mean size about 160 nm, size distribution <0.15, zeta potential around -50 mV), containing sodium oleate in the aqueous phase and polysorbate 80, poloxamer 188 or Solutol(®) HS15 as co-emulsifier, were produced by hot homogenization and their ability to improve risperidone delivery to the brain was assessed in rats. Pharmacokinetic study demonstrated erratic brain profiles of risperidone following intraperitoneal administration in selected nanoemulsions, most probably due to their different droplet surface properties (different composition of the stabilizing layer). Namely, polysorbate 80-costabilized nanoemulsion showed increased (1.4-7.4-fold higher) risperidone brain availability compared to other nanoemulsions and drug solution, suggesting this nanoemulsion as a promising carrier worth exploring further for brain targeting.

1 October 2013 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
BČBojan Čalija
Bojan Čalija
NCNebojša Cekić
Nebojša Cekić
Snezana SavicSnezana Savic
Snezana Savic
Rolf DanielsRolf Daniels
Rolf Daniels
BMBojan Marković
Bojan Marković
JMJela Milić
Jela Milić

1 August 2017 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
VSVedrana Savić
Vedrana Savić
MTMarija Todosijević
Marija Todosijević
TITanja Ilić
Tanja Ilić
Milica LukicMilica Lukic
Milica Lukic
Evgenia MitsouEvgenia Mitsou
Evgenia Mitsou
Snezana SavicSnezana Savic
Snezana Savic

1 November 2013 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
SƉSanela M. Ɖorɖević
Sanela M. Ɖorɖević
TRTamara S. Radulović
Tamara S. Radulović
NCNebojša D. Cekić
Nebojša D. Cekić
DRDanijela V. Randelović
Danijela V. Randelović
MSMiroslav Savić
Miroslav Savić
Snezana SavicSnezana Savic
Snezana Savic

1 November 2017 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
SĐSanela M. Đorđević
Sanela M. Đorđević
ASAnja Santrač
Anja Santrač
NCNebojša D. Cekić
Nebojša D. Cekić
BMBojan D. Marković
Bojan D. Marković
BDBranka Divović
Branka Divović
Snezana SavicSnezana Savic
Snezana Savic